Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
Anbio Biotechnology announces its participation in three major international exhibitions in May 2025: EuroMedLab (Brussels), AVA Conference (Sydney), and ACMTT (Bangkok). The company will showcase its comprehensive diagnostic portfolio including:
- Fluorescence Immunoassay Systems supporting 90 test items
- Dry Chemistry Analyzers for point-of-care biochemical testing
- Rapid Test Kits for on-site diagnostics
- Molecular Diagnostic System featuring LAMP-based technology
- Veterinary Diagnostics Suite for companion animal health
With product registrations in over 100 countries, Anbio is actively seeking distribution partners, research collaborators, and strategic investors to expand its global presence in both human and animal healthcare diagnostics.
Anbio Biotechnology annuncia la sua partecipazione a tre importanti fiere internazionali nel maggio 2025: EuroMedLab (Bruxelles), Conferenza AVA (Sydney) e ACMTT (Bangkok). L'azienda presenterà il suo completo portafoglio diagnostico che comprende:
- Sistemi di Immunodosaggio a Fluorescenza con supporto per 90 test
- Analizzatori di Chimica Secca per test biochimici point-of-care
- Kit di Test Rapidi per diagnosi sul posto
- Sistema Diagnostico Molecolare basato su tecnologia LAMP
- Suite Diagnostica Veterinaria per la salute degli animali da compagnia
Con registrazioni di prodotto in oltre 100 paesi, Anbio è alla ricerca di partner distributivi, collaboratori per la ricerca e investitori strategici per espandere la propria presenza globale nei settori della diagnostica per la salute umana e animale.
Anbio Biotechnology anuncia su participación en tres importantes ferias internacionales en mayo de 2025: EuroMedLab (Bruselas), Conferencia AVA (Sídney) y ACMTT (Bangkok). La empresa presentará su completo portafolio diagnóstico que incluye:
- Sistemas de Inmunoensayo por Fluorescencia con soporte para 90 pruebas
- Analizadores de Química Seca para pruebas bioquímicas en el punto de atención
- Kits de Pruebas Rápidas para diagnóstico in situ
- Sistema de Diagnóstico Molecular con tecnología basada en LAMP
- Suite de Diagnóstico Veterinario para la salud de animales de compañía
Con registros de productos en más de 100 países, Anbio busca activamente socios de distribución, colaboradores en investigación e inversores estratégicos para expandir su presencia global en diagnósticos para la salud humana y animal.
Anbio Biotechnology는 2025년 5월에 개최되는 세 개의 주요 국제 전시회에 참가할 예정입니다: EuroMedLab(브뤼셀), AVA 컨퍼런스(시드니), ACMTT(방콕). 회사는 다음을 포함한 종합적인 진단 제품군을 선보일 예정입니다:
- 형광 면역측정 시스템 90개 검사 항목 지원
- 건식 화학 분석기 현장 생화학 검사용
- 신속 검사 키트 현장 진단용
- 분자 진단 시스템 LAMP 기반 기술 적용
- 수의 진단 제품군 반려동물 건강 관리용
100개국 이상에서 제품 등록을 완료한 Anbio는 인체 및 동물 건강 진단 분야에서 글로벌 입지를 확장하기 위해 유통 파트너, 연구 협력자 및 전략적 투자자를 적극적으로 찾고 있습니다.
Anbio Biotechnology annonce sa participation à trois grandes expositions internationales en mai 2025 : EuroMedLab (Bruxelles), Conférence AVA (Sydney) et ACMTT (Bangkok). L'entreprise présentera son portefeuille complet de diagnostics incluant :
- Systèmes d’Immunodosage par Fluorescence supportant 90 tests
- Analyseurs de Chimie Sèche pour les tests biochimiques au point de soin
- Kits de Tests Rapides pour le diagnostic sur site
- Système de Diagnostic Moléculaire basé sur la technologie LAMP
- Suite de Diagnostic Vétérinaire pour la santé des animaux de compagnie
Avec des enregistrements de produits dans plus de 100 pays, Anbio recherche activement des partenaires de distribution, des collaborateurs en recherche et des investisseurs stratégiques pour étendre sa présence mondiale dans les diagnostics de santé humaine et animale.
Anbio Biotechnology kündigt seine Teilnahme an drei bedeutenden internationalen Messen im Mai 2025 an: EuroMedLab (Brüssel), AVA-Konferenz (Sydney) und ACMTT (Bangkok). Das Unternehmen wird sein umfassendes diagnostisches Portfolio präsentieren, das Folgendes umfasst:
- Fluoreszenz-Immunoassay-Systeme mit Unterstützung für 90 Testverfahren
- Trockene Chemie-Analysatoren für biochemische Tests am Point-of-Care
- Schnelltest-Kits für Vor-Ort-Diagnostik
- Molekulares Diagnosesystem mit LAMP-basierter Technologie
- Veterinärdiagnostik-Suite für die Gesundheit von Begleittieren
Mit Produktregistrierungen in über 100 Ländern sucht Anbio aktiv Vertriebspartner, Forschungspartner und strategische Investoren, um seine globale Präsenz im Bereich der Human- und Tiergesundheitsdiagnostik auszubauen.
- None.
- None.
Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration
BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international exhibitions this May: EuroMedLab 2025 in Brussels, AVA Conference 2025 in Sydney, and the 47th ACMTT 2025 in Bangkok. These events reflect Anbio’s strategic commitment to expanding its global footprint across human and animal healthcare, building new partnerships, and sharing its vision for accessible, high-performance diagnostics.
As healthcare systems around the world seek faster, more accurate, and decentralized testing solutions, Anbio is well-positioned to meet this demand through a diversified portfolio and expanding global network.
“These exhibitions are not just product showcases—they represent Anbio’s mission to reshape diagnostics through collaboration, innovation, and accessibility,” said Michael Lau, CEO of Anbio Biotechnology. “We look forward to connecting with partners and professionals who share our vision of smarter, more inclusive healthcare.”
At all three exhibitions, Anbio will feature its comprehensive diagnostic portfolio designed to meet the needs of both clinical and veterinary professionals. Key solutions include:
- Fluorescence Immunoassay (FIA) Systems: Supports 90 test items, offering rapid and quantitative detection across a broad range of clinical areas—including cardiac markers, hormones, infectious diseases, inflammation, tumor markers and others.
- Dry Chemistry Analyzers: Compact and user-friendly systems designed for essential biochemical testing at the point of care. Utilizing independent test strip-based reagents, offers a simpler, maintenance-free testing experience—ideal for decentralized settings such as community clinics, mobile units, and veterinary practices.
- Rapid Test Kits: Lateral flow and immunoassay-based kits for on-site diagnostics.
- Molecular Diagnostic System: Offers a versatile molecular diagnostics portfolio, including LAMP-based Rapid Mdx System, and real-time RT-PCR reagents. With room temperature-stable reagents and streamlined protocols, these solutions enable faster, more accessible nucleic acid detection.
- Veterinary Diagnostics Suite: Provides a comprehensive diagnostic solution for veterinarians, integrating immunoassays, biochemical testing, and molecular diagnostics. This all-in-one approach supports accurate, efficient, and on-site decision-making for a wide range of companion animal health needs.
These innovations are built on a shared foundation of accuracy, speed, and usability, enabling deployment in hospitals, labs, mobile units, veterinary clinics, and remote field settings.
Global Vision, Local Action
With product registrations in over 100 countries and a growing network of international partners, Anbio continues to pursue a global strategy of innovation, collaboration, and commercialization. Its participation in EuroMedLab, AVA, and ACMTT underscores a commitment to engaging with local markets while driving global standards.
As part of this initiative, Anbio is actively seeking distribution partners, research collaborators, and strategic investors to expand diagnostic access and co-develop market-specific solutions.
About Anbio Biotechnology
Anbio Biotechnology is a globally oriented IVD company focused on empowering healthcare professionals through innovative diagnostic solutions. Its portfolio spans immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, and rapid testing. With strong R&D capabilities and a presence in over 100 countries, Anbio is dedicated to building a healthier world through diagnostics that are fast, accurate, and accessible to all.
For more information about the Anbio Biotechnology, follow us on social media for the latest news and updates.
Contact: jocelyn@anbio.com Jocelyn Chow
FAQ
What products will Anbio Biotechnology showcase at the May 2025 exhibitions?
Which international exhibitions will Anbio Biotechnology attend in May 2025?
How many countries have approved Anbio Biotechnology's products?
What type of partners is Anbio Biotechnology currently seeking?
